C12N 2502/1311
Osteocytes, osteoblasts, odontoblasts
C12N2502/1311 (Osteocytes, osteoblasts, odontoblasts) appears on 47 US grants and 57 published applications in this corpus.
Search patents in C12N- Granted patents
- 47
- Published applications
- 57
- Assignees
- 48
- Inventors
- 125
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 5 |
| 2008 | 1 | 4 |
| 2009 | 1 | 2 |
| 2010 | 1 | 2 |
| 2011 | 2 | 2 |
| 2012 | 2 | 3 |
| 2013 | 0 | 1 |
| 2014 | 6 | 5 |
| 2015 | 4 | 4 |
| 2016 | 0 | 3 |
| 2017 | 4 | 2 |
| 2018 | 2 | 1 |
| 2019 | 2 | 2 |
| 2020 | 0 | 3 |
| 2021 | 2 | 3 |
| 2022 | 2 | 3 |
| 2023 | 3 | 1 |
| 2024 | 2 | 1 |
| 2025 | 3 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Organ chip to model mammalian joint30 Dec 2025US 12,509,653 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Osteoporosis model comprising calcium phosphate hydrogel composition and use thereof18 Mar 2025US 12,252,711 B2Medifab Co., Ltd.
- Modular, microfluidic, mechanically active bioreactor for 3D, multi-tissue, tissue culture25 Feb 2025US 12,234,486 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto3 Dec 2024US 12,156,893 B2The Regents of the University of California
- T regulatory (Treg) cell transplantation in osteogenesis imperfecta (OI)7 May 2024US 11,975,024 B2MUSC Foundation for Research Development
- Mscs and extracellular vesicles7 Aug 2025US 2025/0250545 A1Exostem Biotec Ltd.
- Osteoporosis model comprising calcium phosphate hydrogel composition and use thereof12 Jun 2025US 2025/0188416 A1Medifab Co., Ltd.
- A cellular composite3 Apr 2025US 2025/0109384 A1Alcyomics LTD
- Modular, microfluidic, mechanically active bioreactor for 3d, multi-tissue, tissue culture21 Mar 2024US 2024/0093157 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto23 Nov 2023US 2023/0372415 A1The Regents of the University of California
Most cited
By later US patents
- Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects229US 5,716,616 AThomas Jefferson University · 1998
- Engineering oral tissues137US 5,885,829 AThe Regents of the University of Michigan · 1999
- Hematopoietic cells: compositions and methods95US 5,733,541 AThe Regent of the University of Michigan · 1998
- Isolated stromal cells for use in the treatment of diseases of the central nervous system65US 6,653,134 B2CP Hahnemann University · 2003
- Method for in vitro production of bone37US 6,299,650 B1IsoTis N.V. · 2001